215 related articles for article (PubMed ID: 23452770)
1. Treatment of chronic immune-mediated neuropathies: impact of the rare diseases centers network in Italy.
Nobile-Orazio E
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S33-8. PubMed ID: 23452770
[TBL] [Abstract][Full Text] [Related]
2. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
3. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
4. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
5. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based treatment of chronic immune-mediated neuropathies.
Magy L; Vallat JM
Expert Opin Pharmacother; 2009 Aug; 10(11):1741-54. PubMed ID: 19601698
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.
Lewis RA
Semin Neurol; 2005 Jun; 25(2):217-28. PubMed ID: 15937737
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
10. Update on therapy of chronic immune-mediated neuropathies.
Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
[TBL] [Abstract][Full Text] [Related]
12. What is new in 2015 in dysimmune neuropathies?
Kuntzer T
Rev Neurol (Paris); 2016 Dec; 172(12):779-784. PubMed ID: 27866728
[TBL] [Abstract][Full Text] [Related]
13. Treatment of dys-immune neuropathies.
Nobile-Orazio E
J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
Latov N
Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
[TBL] [Abstract][Full Text] [Related]
16. Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies.
Nobile-Orazio E; Giannotta C
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():18-23. PubMed ID: 21696492
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
Collet R; Caballero-Ávila M; Querol L
Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
[TBL] [Abstract][Full Text] [Related]
18. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
20. Treatment of inflammatory and paraproteinemic neuropathies.
Monaco S; Turri E; Zanusso G; Maistrello B
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
